Mangoceuticals (NASDAQ:MGRX) Issues Quarterly Earnings Results

Mangoceuticals (NASDAQ:MGRX) posted its earnings results on Thursday. The company reported ($1.01) earnings per share (EPS) for the quarter, Zacks reports. Mangoceuticals had a negative net margin of 1,237.00% and a negative return on equity of 138.00%.

Mangoceuticals Stock Up 1.9 %

Shares of MGRX traded up $0.08 on Thursday, hitting $4.35. The company’s stock had a trading volume of 65,411 shares, compared to its average volume of 225,913. The firm’s fifty day moving average price is $3.75 and its 200-day moving average price is $14.74. Mangoceuticals has a fifty-two week low of $2.07 and a fifty-two week high of $16.80. The firm has a market capitalization of $10.82 million, a price-to-earnings ratio of -0.75 and a beta of 1.51.

About Mangoceuticals

Mangoceuticals, Inc develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com.